Hospital Universitario Walter Cantidio

Fortaleza 60430-372

2 studies enrolling now · 4 studies all time

What they study most

C3 Glomerulonephritis, C3 Glomerulopathy, C3G, Central Precocious Puberty, Complement 3 Glomerulonephritis, Complement 3 Glomerulopathy, Complement 3 Glomerulopathy (C3G), DDD, Dense Deposit Disease, Diabetes Mellitus, Type 1, IC-MPGN, Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — Recruiting now
• A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial) — Running, not enrolling
• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis — Completed